BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37653425)

  • 21. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
    Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
    Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
    Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
    Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
    JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia.
    Li K; Du Y; Cai Y; Liu W; Lv Y; Huang B; Zhang L; Wang Z; Liu P; Sun Q; Li N; Zhu M; Bosco B; Li L; Wu W; Wu L; Li J; Wang Q; Hong M; Qian S
    Leukemia; 2023 Feb; 37(2):308-325. PubMed ID: 36543880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clones.
    Saeed BR; Manta L; Raffel S; Pyl PT; Buss EC; Wang W; Eckstein V; Jauch A; Trumpp A; Huber W; Ho AD; Lutz C
    Int J Cancer; 2021 Jun; 148(11):2825-2838. PubMed ID: 33411954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Expression Pattern of CD33 Antigen Can Differentiate Leukemic from Normal Progenitor Cells in Acute Myeloid Leukemia.
    Dutta S; Saxena R
    Indian J Hematol Blood Transfus; 2014 Jun; 30(2):130-4. PubMed ID: 24839368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells.
    Gal H; Amariglio N; Trakhtenbrot L; Jacob-Hirsh J; Margalit O; Avigdor A; Nagler A; Tavor S; Ein-Dor L; Lapidot T; Domany E; Rechavi G; Givol D
    Leukemia; 2006 Dec; 20(12):2147-54. PubMed ID: 17039238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia.
    Zhai Y; Singh P; Dolnik A; Brazda P; Atlasy N; Del Gaudio N; Döhner K; Döhner H; Minucci S; Martens J; Altucci L; Megchelenbrink W; Bullinger L; Stunnenberg HG
    Mol Cancer; 2022 Aug; 21(1):166. PubMed ID: 35986270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts.
    Siehl JM; Thiel E; Leben R; Reinwald M; Knauf W; Menssen HD
    Bone Marrow Transplant; 2002 Mar; 29(5):379-81. PubMed ID: 11919726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
    Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
    Agarwal P; Bhatia R
    Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
    Sievers EL; Lange BJ; Buckley JD; Smith FO; Wells DA; Daigneault-Creech CA; Shults KE; Bernstein ID; Loken MR
    J Natl Cancer Inst; 1996 Oct; 88(20):1483-8. PubMed ID: 8841024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia.
    Beneyto-Calabuig S; Merbach AK; Kniffka JA; Antes M; Szu-Tu C; Rohde C; Waclawiczek A; Stelmach P; Gräßle S; Pervan P; Janssen M; Landry JJM; Benes V; Jauch A; Brough M; Bauer M; Besenbeck B; Felden J; Bäumer S; Hundemer M; Sauer T; Pabst C; Wickenhauser C; Angenendt L; Schliemann C; Trumpp A; Haas S; Scherer M; Raffel S; Müller-Tidow C; Velten L
    Cell Stem Cell; 2023 May; 30(5):706-721.e8. PubMed ID: 37098346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
    Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
    Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.
    Shingai Y; Yokota T; Okuzaki D; Sudo T; Ishibashi T; Doi Y; Ueda T; Ozawa T; Nakai R; Tanimura A; Ichii M; Shibayama H; Kanakura Y; Hosen N
    Stem Cells; 2021 Jun; 39(6):723-736. PubMed ID: 33539590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.